Mustang Bio (MBIO) Total Current Liabilities (2016 - 2026)
Mustang Bio (MBIO) posted quarterly Total Current Liabilities of $7.8 million for Q1 2026, down 29.72% year-over-year from $11.2 million in Q1 2025, and down 0.99% quarter-over-quarter from $7.9 million in Q4 2025.
Mustang Bio (MBIO) Total Current Liabilities (2016 - 2026) Analysis & Trends
Mustang Bio (MBIO) has reported Total Current Liabilities for 11 consecutive years, with $7.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 29.72% year-over-year to $7.8 million; the TTM figure through Mar 2026 stood at $7.8 million (down 29.72% YoY), while the FY2025 annual figure was $7.9 million, down 37.24% from the prior year.
- Total Current Liabilities retreated to $7.8 million in Q1 2026 per MBIO's latest filing, from $7.9 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $17.4 million in Q1 2024 and bottomed at $7.8 million in Q1 2026.
- Historically, Total Current Liabilities has averaged $12.5 million across 5 years, with a median of $12.7 million in 2023.
- Annual changes were most pronounced in 2022 — Total Current Liabilities surged 72.63% — and 2025, when it plunged 37.24%.
- Mustang Bio's Total Current Liabilities stood at $15.1 million in 2022, then grew by 1.73% to $15.4 million in 2023, then fell by 17.97% to $12.6 million in 2024, then slumped by 37.24% to $7.9 million in 2025, then decreased by 0.99% to $7.8 million in 2026.
- Business Quant data shows MBIO's Total Current Liabilities at $7.8 million in Q1 2026, $7.9 million in Q4 2025, and $9.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 630.93 Mn |
| 10 | Mustang Bio | 3.90 Mn | 3.90 Mn | - | 7.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.92 Mn |
| Mar 31, 2026 | 7.84 Mn |
| Dec 31, 2025 | 7.91 Mn |
| Sep 30, 2025 | 9.44 Mn |
| Jun 30, 2025 | 10.00 Mn |
| Mar 31, 2025 | 11.15 Mn |
| Dec 31, 2024 | 12.61 Mn |
| Sep 30, 2024 | 15.04 Mn |
| Jun 30, 2024 | 15.92 Mn |
| Mar 31, 2024 | 17.44 Mn |
| Dec 31, 2023 | 15.37 Mn |
| Sep 30, 2023 | 14.17 Mn |
| Jun 30, 2023 | 12.86 Mn |
| Mar 31, 2023 | 12.67 Mn |
| Dec 31, 2022 | 15.11 Mn |
| Sep 30, 2022 | 13.56 Mn |
| Jun 30, 2022 | 10.98 Mn |
| Mar 31, 2022 | 10.78 Mn |
| Dec 31, 2021 | 10.82 Mn |
| Sep 30, 2021 | 10.46 Mn |